{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:07:35Z","timestamp":1793210855107,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T00:00:00Z","timestamp":1520208000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00415-018-8811-1","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T05:05:02Z","timestamp":1520226302000},"page":"1096-1101","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Autoimmune comorbidities in multiple sclerosis: what is the influence on brain volumes? A case\u2013control MRI study"],"prefix":"10.1007","volume":"265","author":[{"given":"Lorena","family":"Lorefice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Fenu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Pitzalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Scalas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Frau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Coghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigina","family":"Musu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Sechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"Barracciu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giovanna","family":"Marrosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Cocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,5]]},"reference":[{"issue":"Pt 3","key":"8811_CR1","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/brain\/awv398","volume":"139","author":"L Haider","year":"2016","unstructured":"Haider L, Zrzavy T, Hametner S et al (2016) The topography of demyelination and neurodegeneration in the multiple sclerosis brain. Brain 139(Pt 3):807\u2013815","journal-title":"Brain"},{"issue":"1","key":"8811_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1615\/CritRevImmunol.v17.i1.20","volume":"17","author":"P Stinissen","year":"1997","unstructured":"Stinissen P, Raus J, Zhang J (1997) Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies. Crit Rev Immunol 17(1):33\u201375","journal-title":"Crit Rev Immunol"},{"issue":"3","key":"8811_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1750-3639.1996.tb00854.x","volume":"6","author":"CF Lucchinetti","year":"1996","unstructured":"Lucchinetti CF, Br\u00fcck W, Rodriguez M et al (1996) Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol 6(3):259\u2013274","journal-title":"Brain Pathol"},{"issue":"1","key":"8811_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ncl.2017.08.002","volume":"36","author":"HN Lemus","year":"2018","unstructured":"Lemus HN, Warrington AE, Rodriguez M (2018) Multiple sclerosis: mechanisms of disease and strategies for myelin and axonal repair. Neurol Clin 36(1):1\u201311","journal-title":"Neurol Clin"},{"issue":"9316","key":"8811_CR5","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/S0140-6736(02)08431-3","volume":"359","author":"MG Marrosu","year":"2002","unstructured":"Marrosu MG, Cocco E, Lai M et al (2002) Patients with multiple sclerosis and risk of type 1 diabetes mellitus in Sardinia, Italy: a cohort study. Lancet 359(9316):1461\u20131465","journal-title":"Lancet"},{"issue":"1\u20132","key":"8811_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jns.2014.11.019","volume":"348","author":"P Tettey","year":"2015","unstructured":"Tettey P, Simpson S Jr, Taylor BV et al (2015) The co-occurrence of multiple sclerosis and type 1 diabetes: shared aetiologic features and clinical implication for MS aetiology. J Neurol Sci 348(1\u20132):126\u2013131","journal-title":"J Neurol Sci"},{"issue":"3","key":"8811_CR7","doi-asserted-by":"publisher","first-page":"e32487","DOI":"10.1371\/journal.pone.0032487","volume":"7","author":"C Sardu","year":"2012","unstructured":"Sardu C, Cocco E, Mereu A et al (2012) Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity. PLoS ONE 7(3):e32487","journal-title":"PLoS ONE"},{"issue":"3","key":"8811_CR8","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1177\/1352458514564490","volume":"21","author":"RA Marrie","year":"2015","unstructured":"Marrie RA, Reider N, Cohen J et al (2015) A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis. Mult Scler. 21(3):282\u2013293","journal-title":"Mult Scler."},{"issue":"7","key":"8811_CR9","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S1474-4422(10)70094-6","volume":"9","author":"SV Ramagopalan","year":"2010","unstructured":"Ramagopalan SV, Dobson R, Meier UC et al (2010) Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol. 9(7):727\u2013739","journal-title":"Lancet Neurol."},{"issue":"17","key":"8811_CR10","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1056\/NEJMoa1610528","volume":"376","author":"M Steri","year":"2017","unstructured":"Steri M, Orr\u00f9 V, Idda ML et al (2017) Overexpression of the cytokine BAFF and autoimmunity risk. N Engl J Med 376(17):1615\u20131626","journal-title":"N Engl J Med"},{"issue":"4","key":"8811_CR11","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1212\/WNL.53.4.883","volume":"53","author":"A Karni","year":"1999","unstructured":"Karni A, Abramsky O (1999) Association of MS with thyroid disorders. Neurology. 53(4):883\u2013885","journal-title":"Neurology."},{"issue":"11","key":"8811_CR12","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.2337\/diacare.26.11.3192","volume":"26","author":"JS Dorman","year":"2003","unstructured":"Dorman JS, Steenkiste AR, Burke JP, Songini M (2003) Type 1 diabetes and multiple sclerosis: together at last. Diabetes Care 26(11):3192\u20133193","journal-title":"Diabetes Care"},{"key":"8811_CR13","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1001\/archneur.63.7.1001","volume":"63","author":"NM Nielsen","year":"2006","unstructured":"Nielsen NM, Westergaard T, Frisch M et al (2006) Type 1 diabetes and multiple sclerosis: a Danish population-based cohort study. Arch Neurol 63:1001\u20131004","journal-title":"Arch Neurol"},{"key":"8811_CR14","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.2337\/dc06-0811","volume":"29","author":"WI Hussein","year":"2006","unstructured":"Hussein WI, Reddy SS (2006) Prevalence of diabetes in patients with multiple sclerosis. Diabetes Care 29:1984\u20131985","journal-title":"Diabetes Care"},{"issue":"6","key":"8811_CR15","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1034\/j.1399-0039.2000.560605.x","volume":"56","author":"R Lampis","year":"2000","unstructured":"Lampis R, Morelli L, De Virgiliis S et al (2000) The distribution of HLA class II haplotypes reveals that the Sardinian population is genetically differentiated from the other Caucasian populations. Tissue Antigens 56(6):515\u2013521","journal-title":"Tissue Antigens"},{"issue":"10","key":"8811_CR16","doi-asserted-by":"publisher","first-page":"e1005757","DOI":"10.1371\/journal.pcbi.1005757","volume":"13","author":"E Kotelnikova","year":"2017","unstructured":"Kotelnikova E, Kiani NA, Abad E et al (2017) Dynamics and heterogeneity of brain damage in multiple sclerosis. PLoS Comput Biol 13(10):e1005757","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"8811_CR17","first-page":"93","volume":"87","author":"N Stefano De","year":"2016","unstructured":"De Stefano N, Stromillo ML, Giorgio A et al (2016) Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis. J Neurol Neurosurg Psychiatry 87(1):93\u201399","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8811_CR18","first-page":"135245851773614","volume":"1","author":"A Pichler","year":"2017","unstructured":"Pichler A, Khalil M, Langkammer C et al (2017) The impact of vascular risk factors on brain volume and lesion load in patients with early multiple sclerosis. Mult Scler. 1:1352458517736149","journal-title":"Mult Scler."},{"issue":"6","key":"8811_CR19","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.3174\/ajnr.A4681","volume":"37","author":"R Zivadinov","year":"2016","unstructured":"Zivadinov R, Raj B, Ramanathan M et al (2016) Autoimmune comorbidities are associated with brain injury in multiple sclerosis. AJNR Am J Neuroradiol 37(6):1010\u20131016","journal-title":"AJNR Am J Neuroradiol"},{"issue":"11","key":"8811_CR20","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1177\/1352458511408754","volume":"17","author":"E Cocco","year":"2011","unstructured":"Cocco E, Sardu C, Massa R et al (2011) Epidemiology of multiple sclerosis in south-western Sardinia. Mult Scler. 17(11):1282\u20131289","journal-title":"Mult Scler."},{"issue":"2","key":"8811_CR21","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292\u2013302","journal-title":"Ann Neurol"},{"issue":"11","key":"8811_CR22","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444\u20131452","journal-title":"Neurology"},{"issue":"4","key":"8811_CR23","first-page":"5","volume":"137","author":"WS Cendrowski","year":"1986","unstructured":"Cendrowski WS (1986) Progression index and disability status in multiple sclerosis: a resurvey of 207 patients in central Poland. Schweiz Arch Neurol Psychiatr (1985). 137(4):5\u201313","journal-title":"Schweiz Arch Neurol Psychiatr (1985)."},{"issue":"1","key":"8811_CR24","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1006\/nimg.2002.1040","volume":"17","author":"SM Smith","year":"2002","unstructured":"Smith SM, Zhang Y, Jenkinson M et al (2002) Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage. 17(1):479\u2013489","journal-title":"Neuroimage."},{"key":"8811_CR25","doi-asserted-by":"publisher","first-page":"9295","DOI":"10.1016\/j.clineuro.2016.09.003","volume":"150","author":"MA Sahraian","year":"2016","unstructured":"Sahraian MA, Owji M, Naser Moghadasi A (2016) Concomitant multiple sclerosis and another autoimmune disease: does the clinical course change? Clin Neurol Neurosurg 150:9295","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"8811_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jmri.23671","volume":"37","author":"A Giorgio","year":"2013","unstructured":"Giorgio A, De Stefano N (2013) Clinical use of brain volumetry. J Magn Reson Imaging 37(1):1\u201314","journal-title":"J Magn Reson Imaging"},{"key":"8811_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s40263-014-0140-z","volume":"28","author":"N Stefano De","year":"2014","unstructured":"De Stefano N, Airas L, Grigoriadis N et al (2014) Clinical relevance of brain volume measures in multiple sclerosis. CNS Drugs 28:147\u2013156","journal-title":"CNS Drugs"},{"issue":"4","key":"8811_CR28","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.4049\/jimmunol.166.4.2831","volume":"166","author":"S Winer","year":"2001","unstructured":"Winer S, Astsaturov I, Cheung R et al (2001) Type I diabetes and multiple sclerosis patients target islet plus central nervous system autoantigens; nonimmunized nonobese diabetic mice can develop autoimmune encephalitis. J Immunol. 166(4):2831\u20132841","journal-title":"J Immunol."},{"issue":"4","key":"8811_CR29","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/ana.22230","volume":"68","author":"R Magliozzi","year":"2010","unstructured":"Magliozzi R, Howell OW, Reeves C et al (2010) Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol 68(4):477\u2013493","journal-title":"Ann Neurol"},{"issue":"3","key":"8811_CR30","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2337\/dc11-1290","volume":"35","author":"GS Pell","year":"2012","unstructured":"Pell GS, Lin A, Wellard RM et al (2012) Age-related loss of brain volume and T2 relaxation time in youth with type 1 diabetes. Diabetes Care 35(3):513\u2013519","journal-title":"Diabetes Care"},{"issue":"9","key":"8811_CR31","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.2337\/dc07-0351","volume":"30","author":"DC Perantie","year":"2007","unstructured":"Perantie DC, Wu J, Koller JM, Lim A, Warren SL, Black KJ, Sadler M, White NH, Hershey T (2007) Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes. Diabetes Care 30(9):2331\u20132337","journal-title":"Diabetes Care"},{"key":"8811_CR32","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1212\/01.wnl.0000257815.20548.df","volume":"68","author":"AL Jefferson","year":"2007","unstructured":"Jefferson AL, Massaro JM, Wolf PA et al (2007) Inflammatory biomarkers are associated with total brain volume: the Framingham Heart Study. Neurology 68:1032\u20131038","journal-title":"Neurology"},{"key":"8811_CR33","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1212\/WNL.0b013e3181d6b125","volume":"74","author":"RA Marrie","year":"2010","unstructured":"Marrie RA, Rudick R, Horwitz R et al (2010) Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology 74:1041\u20131047","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-018-8811-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-8811-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-8811-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T01:47:00Z","timestamp":1551750420000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-018-8811-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["8811"],"URL":"https:\/\/doi.org\/10.1007\/s00415-018-8811-1","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,5]]},"assertion":[{"value":"19 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Lorefice has received speaker fees from Teva and serves on scientific advisory boards for Biogen. Dr. Fenu has received honoraria for consultancy from Novartis and for speaking from Merck Serono and Teva. Dr. Frau serves on scientific advisory boards for Biogen, and has received honoraria for speaking from Merck Serono and Teva. Dr. Coghe has received speaker fees from Teva and Almirall. Professors Cocco and Marrosu have received honoraria for consultancy or speaking from Bayer, Biogen, Novartis, Sanofi, Genzyme, Serono, and Teva. Dr. Barracciu, Dr. Musu, Dr. Pitzalis, Dr. Sechi, and Dr. Scalas have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was performed in accordance with the ethical standards statement.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}